As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

The U.S. Supreme Court upheld the Affordable Care Act, ensuring its longevity, while ICD-10 was implemented with much handwringing, among other notable milestones. These major healthcare decisions ...

Compared to the last administration, it’s like the dark of night and the light of day,” Alexandria Real Estate's founder said ...

A district court in New Jersey ruled that the plaintiff lacked standing for certain claims, but there is a chance the case ...

As the year begins under a new Trump Administration, healthcare providers and private equity firms should consider the antitrust ...